APP and Alzheimer disease: Studies have shown that the CpG site on the APP gene promoter is hypomethylated in Alzheimer's disease (AD) of the brain, causing the overexpression of amyloid precursor protein, hence overproduction and abnormal metabolism of Aβ [12].